OPEN END TURBO LONG - MERCK & CO. | Real-time Bid/Ask 11:40:30 2024-06-21 EDT | ||
| 3.77 EUR / 3.78 EUR | -0.40% |
|
| Current month | +14.16% | ||
| 1 month | -1.81% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-06-21 | 3.77 | -0.53% |
| 24-06-20 | 3.79 | +7.37% |
| 24-06-19 | 3.53 | -1.67% |
| 24-06-18 | 3.59 | +0.84% |
| 24-06-17 | 3.56 | -3.52% |
Delayed Quote Börse Stuttgart
Last update June 21, 2024 at 07:00 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MD3644 |
| ISIN | DE000MD36448 |
| Date issued | 2022-04-05 |
| Strike | 89.52 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.53 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.15 € |
|---|---|
| Lowest since issue | 0.5 € |
| Spread | 0.01 € |
| Spread % | 0.27% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.7
USD
Average target price
142.7
USD
Spread / Average Target
+10.03%
- Stock Market
- Certificates
- Certificat
